Home › Companies › CLOVER HEALTH INVESTMENTS CORP. › 2024-2025
Compiled from SEC Form N-PX filings and CLOVER HEALTH INVESTMENTS CORP.’s Form 8-K, filed June 12, 2025 (Item 5.07 on EDGAR). Page generated October 14, 2026.
Meeting of June 10, 2025: 4 items on CLOVER HEALTH INVESTMENTS CORP.’s Form 8-K, filed June 12, 2025: 2 elected · 1 approved · 1 without a stated outcome.
None.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore CLOVER HEALTH INVESTMENTS CORP. in the interactive database Compare manager voting policies
These tallies are CLOVER HEALTH INVESTMENTS CORP.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Anna U. Loengard, M.D. | 976,901,062 | -- | -- | 20,121,520 | 161,993,043 | 98% | Elected | — |
| Elect Director: William G. Robinson, Jr. | 969,995,918 | -- | -- | 27,026,664 | 161,993,043 | 97% | Elected | — |
| 2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2024 | 988,724,280 | 6,196,982 | 2,101,320 | -- | 161,993,043 | 99.3% | Not verified | — |
| 3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025 | 1,154,406,035 | 3,060,080 | 1,549,510 | -- | -- | 99.7% | Approved | — |
Source: CLOVER HEALTH INVESTMENTS CORP., Form 8-K, filed with the SEC on June 12, 2025 — read the filing on EDGAR.
Each item below shows how the 127 asset managers that disclosed a CLOVER HEALTH INVESTMENTS CORP. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
98% Majority: yes · of votes cast
Description as filed by funds: DIRECTOR: ANNA U. LOENGARD, M.D.
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: Anna U. Loengard, M.D.”): 976,901,062 for, 20,121,520 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Dr. Anna U. Loengard and William G. Robinson, Jr. were each elected to the Company's Board of Directors as Class I directors, to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 30,055,289 for, 2,793,167 withheld, 6,910 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,087,809 | 0 | 0 | 0 | For |
| Fidelity | 4,554,928 | 0 | 0 | 0 | For |
| Charles Schwab | 2,642,615 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 1,495,371 | Withhold |
| Invesco | 1,123,663 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 914,927 | Withhold |
| BlackRock | 687,686 | 0 | 0 | 0 | For |
| State Street | 472,340 | 0 | 0 | 1,477 | For |
| Victory Capital | 0 | 0 | 0 | 381,298 | Withhold |
| JPMorgan | 133,802 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 126,051 | 0 | 0 | 0 | For |
| Cambria ETF Trust | 115,514 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 45,557 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,950 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,548 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,910 | 0 | Abstain |
| Innovator ETFs Trust | 3,287 | 0 | 0 | 0 | For |
| Northern Trust | 2,826 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 1,847 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 1,556 | 0 | 0 | 0 | For |
| RBB Fund Trust | 310 | 0 | 0 | 0 | For |
| E Trade Trust | 0 | 0 | 0 | 94 | Withhold |
Combines 4 wordings of this item as funds reported it.
97% Majority: yes · of votes cast
Description as filed by funds: DIRECTOR: WILLIAM G. ROBINSON JR.
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“Elect Director: William G. Robinson, Jr.”): 969,995,918 for, 27,026,664 withheld, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Dr. Anna U. Loengard and William G. Robinson, Jr. were each elected to the Company's Board of Directors as Class I directors, to serve until the 2028 annual meeting of stockholders and until their successors are duly elected and qualified.”
Support: 97% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 25,720,525 for, 7,127,931 withheld, 6,910 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,087,809 | 0 | 0 | 0 | For |
| Fidelity | 222,990 | 0 | 0 | 4,331,938 | Withhold |
| Charles Schwab | 2,642,615 | 0 | 0 | 0 | For |
| First Trust | 0 | 0 | 0 | 1,495,371 | Withhold |
| Invesco | 1,123,663 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 914,927 | Withhold |
| BlackRock | 687,686 | 0 | 0 | 0 | For |
| State Street | 472,340 | 0 | 0 | 1,477 | For |
| Victory Capital | 0 | 0 | 0 | 381,298 | Withhold |
| JPMorgan | 133,802 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 126,051 | 0 | 0 | 0 | For |
| Cambria ETF Trust | 115,514 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 45,557 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,950 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,548 | 0 | 0 | 0 | For |
| John Hancock | 0 | 0 | 6,910 | 0 | Abstain |
| Innovator ETFs Trust | 3,287 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 2,826 | Withhold |
| WILSHIRE MUTUAL FUNDS INC | 1,847 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 1,556 | 0 | 0 | 0 | For |
| RBB Fund Trust | 310 | 0 | 0 | 0 | For |
| E Trade Trust | 0 | 0 | 0 | 94 | Withhold |
Combines 10 wordings of this item as funds reported it.
99.3% Majority: yes · of votes cast
Description as filed by funds: Non-binding advisory proposal to approve the compensation paid to our named executive officers for 2024.
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“2. Non-binding advisory vote to approve the compensation of the Company's Named Executive Officers for 2024”): 988,724,280 for, 6,196,982 against, per its Form 8-K filed June 12, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 99.3% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,087,809 | 0 | 0 | 0 | For |
| Fidelity | 4,554,928 | 0 | 0 | 0 | For |
| Charles Schwab | 2,642,615 | 0 | 0 | 0 | For |
| First Trust | 1,495,371 | 0 | 0 | 0 | For |
| Invesco | 1,123,663 | 0 | 0 | 0 | For |
| American Century | 914,927 | 0 | 0 | 0 | For |
| BlackRock | 687,686 | 0 | 0 | 0 | For |
| State Street | 473,817 | 0 | 0 | 0 | For |
| Victory Capital | 381,298 | 0 | 0 | 0 | For |
| JPMorgan | 133,802 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 126,051 | 0 | 0 | 0 | For |
| Cambria ETF Trust | 115,514 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 45,557 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,950 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,548 | 0 | 0 | 0 | For |
| John Hancock | 6,910 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 3,287 | 0 | 0 | 0 | For |
| Northern Trust | 2,826 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 1,847 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 1,556 | 0 | 0 | 0 | For |
| RBB Fund Trust | 310 | 0 | 0 | 0 | For |
| E Trade Trust | 94 | 0 | 0 | 0 | For |
Fund voting reports, all 22 managers: 32,855,366 for.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Renaissance | 8,814,556 | 0 | 0 | 0 | For |
| BlackRock | 7,691,720 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 5,063,212 | 0 | 0 | 0 | For |
| Charles Schwab | 2,642,652 | 0 | 0 | 0 | For |
| State Street | 2,631,418 | 0 | 0 | 0 | For |
| MARSHALL WACE, LLP | 2,599,127 | 0 | 0 | 0 | For |
| Citadel | 1,260,072 | 0 | 0 | 0 | For |
| Invesco | 1,133,874 | 0 | 0 | 0 | For |
| Northern Trust | 992,940 | 0 | 0 | 0 | For |
| American Century | 916,223 | 0 | 0 | 0 | For |
| Vanguard | 747,739 | 0 | 0 | 0 | For |
| GMT CAPITAL CORP | 701,600 | 0 | 0 | 0 | For |
| Connor, Clark & Lunn Investment Management Ltd. | 651,355 | 0 | 0 | 0 | For |
| JUPITER ASSET MANAGEMENT LTD | 647,777 | 0 | 0 | 0 | For |
| TEACHER RETIREMENT SYSTEM OF TEXAS | 571,338 | 0 | 0 | 0 | For |
| UBS | 0 | 515,152 | 0 | 0 | Against |
| Victory Capital | 381,298 | 0 | 0 | 0 | For |
| Allianz | 0 | 367,162 | 0 | 0 | Against |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 351,446 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 290,761 | 0 | 0 | Against |
| OMERS ADMINISTRATION Corp | 206,200 | 0 | 0 | 0 | For |
| SECTORAL ASSET MANAGEMENT INC | 183,000 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 166,724 | 0 | 0 | 0 | For |
| WASHINGTON STATE INVESTMENT BOARD | 165,433 | 0 | 0 | 0 | For |
| T. Rowe Price | 152,500 | 0 | 0 | 0 | For |
Institutional-manager reports, all 114 managers: 40,354,496 for, 1,181,175 against, 116,325 abstained. Showing the 25 largest; see all in the interactive database.
99.7% Approved · of votes cast
Description as filed by funds: THE RATIFICATION OF THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM.
CLOVER HEALTH INVESTMENTS CORP.’s own tally for this item (“3. Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2025”): 1,154,406,035 for, 3,060,080 against — passed, per its Form 8-K filed June 12, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The stockholders ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025.”
Support: 99.7% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 22 asset managers below reported 32,724,472 for, 130,894 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 20,087,809 | 0 | 0 | 0 | For |
| Fidelity | 4,554,928 | 0 | 0 | 0 | For |
| Charles Schwab | 2,642,615 | 0 | 0 | 0 | For |
| First Trust | 1,495,371 | 0 | 0 | 0 | For |
| Invesco | 1,123,663 | 0 | 0 | 0 | For |
| American Century | 914,927 | 0 | 0 | 0 | For |
| BlackRock | 687,686 | 0 | 0 | 0 | For |
| State Street | 473,817 | 0 | 0 | 0 | For |
| Victory Capital | 381,298 | 0 | 0 | 0 | For |
| JPMorgan | 133,802 | 0 | 0 | 0 | For |
| NORTHERN LIGHTS FUND TRUST III | 0 | 126,051 | 0 | 0 | Against |
| Cambria ETF Trust | 115,514 | 0 | 0 | 0 | For |
| Advisor Managed Portfolios | 45,557 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 31,950 | 0 | 0 | 0 | For |
| Goldman Sachs | 23,548 | 0 | 0 | 0 | For |
| John Hancock | 6,910 | 0 | 0 | 0 | For |
| Innovator ETFs Trust | 0 | 3,287 | 0 | 0 | Against |
| Northern Trust | 2,826 | 0 | 0 | 0 | For |
| WILSHIRE MUTUAL FUNDS INC | 1,847 | 0 | 0 | 0 | For |
| Advisors' Inner Circle Fund III | 0 | 1,556 | 0 | 0 | Against |
| RBB Fund Trust | 310 | 0 | 0 | 0 | For |
| E Trade Trust | 94 | 0 | 0 | 0 | For |
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 497,056,331 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 4.04% |
| 2 | Fidelity | 0.92% |
| 3 | Charles Schwab | 0.53% |
| 4 | First Trust | 0.30% |
| 5 | Invesco | 0.23% |
| 6 | American Century | 0.18% |
| 7 | BlackRock | 0.14% |
| 8 | State Street | 0.10% |
| 9 | Victory Capital | 0.08% |
| 10 | JPMorgan | 0.03% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Renaissance | 1.77% |
| 2 | BlackRock | 1.55% |
| 3 | GEODE CAPITAL MANAGEMENT, LLC | 1.02% |
| 4 | Charles Schwab | 0.53% |
| 5 | State Street | 0.53% |
| 6 | MARSHALL WACE, LLP | 0.52% |
| 7 | Citadel | 0.25% |
| 8 | Invesco | 0.23% |
| 9 | Northern Trust | 0.20% |
| 10 | American Century | 0.18% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Entities affiliated with Vivek Garipalli | 16.82% | DEF14A |
| Vanguard Group | 4.14% | 13F |
| Renaissance Technologies | 2.22% | 13F |
| BlackRock | 2.09% | 13F |
| Millennium Management | 1.17% | 13F |
| Geode Capital | 1.01% | 13F |
| Andrew Toy | 0.86% | DEF14A |
| Citadel Advisors | 0.65% | 13F |
| State Street | 0.59% | 13F |
| Charles Schwab | 0.53% | 13F |
Percentages above are of 497,056,331 shares outstanding, as reported by CLOVER HEALTH INVESTMENTS CORP. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from CLOVER HEALTH INVESTMENTS CORP.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.
At CLOVER HEALTH INVESTMENTS CORP.'s shareholder meeting held June 10, 2025, in the 2024-2025 proxy season, 127 asset managers reported how they voted on 4 ballot items in their SEC Form N-PX filings, covering 373 separate fund positions. On the most widely held item on that ballot — Non-binding advisory proposal to approve the compensation paid to our named executive officers… — FOR was 99.3% of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side), which is more than half. Whether the item was approved is for the filing to say; that statement has not been read for this item. Source: CLOVER HEALTH INVESTMENTS CORP.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2025.
CLOVER HEALTH INVESTMENTS CORP. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.